BBOTVSSNYR• 6 Months (Normalized)
BBOT vs SNYR (BridgeBio Oncology Therapeutics Inc. vs Synergy CHC Corp.)
Showing Closing Date Range from Apr 8 to Oct 5, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-54.98%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
SNYR Performance $0.01
+%
Synergy CHC Corp.
Normalized Baseline0.00%
Alpha Spread Margin SNYR LEADS
-54.98 pts
SNYR outperforming by 54.98 percentage points
BBOTSNYR
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT SNYR
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(123 dates)
| Date | BBOT Price | BBOT Gain (%) | SNYR Price | SNYR Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -54.98% | $- | - | |
| Sep 30, 2026 | $4.10 | -52.55% | $- | - | |
| Sep 29, 2026 | $3.92 | -54.63% | $- | - | |
| Sep 28, 2026 | $3.81 | -55.90% | $0.01 | -97.77% | +41.87% |
| Sep 25, 2026 | $3.95 | -54.28% | $0.01 | -97.88% | +43.60% |
| Sep 24, 2026 | $3.99 | -53.82% | $- | - | |
| Sep 23, 2026 | $4.16 | -51.85% | $- | - | |
| Sep 22, 2026 | $4.66 | -46.06% | $0.03 | -95.65% | +49.59% |
| Sep 21, 2026 | $4.66 | -46.06% | $0.04 | -93.60% | +47.54% |
| Sep 18, 2026 | $4.77 | -44.79% | $0.05 | -91.58% | +46.79% |
| Sep 17, 2026 | $4.89 | -43.40% | $0.09 | -85.88% | +42.48% |
| Sep 16, 2026 | $4.76 | -44.91% | $0.27 | -57.25% | +12.34% |
| Sep 15, 2026 | $4.88 | -43.52% | $0.08 | -87.21% | +43.69% |
| Sep 14, 2026 | $5.05 | -41.55% | $0.09 | -85.80% | +44.25% |
| Sep 11, 2026 | $4.95 | -42.71% | $0.10 | -84.24% | +41.53% |
Page 1 of 9